Frontlight ResearchEarly access
Polycystic kidney disease trials in Italy
3 of 6 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Active, not recruitingANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Where
- Bari, Modena, Rome
- Age
- 18 years to 55 years
- People
- 240 worldwide
- Run by
- Calico Life Sciences LLC
See details and how to joinNCT06902558 · EU 2024-517143-31-00 - No phaseTaking peopleDeveloping a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases
- Where
- Ranica
- People
- 105
- Run by
- Mario Negri Institute for Pharmacological Research
See details and how to joinNCT05996731 - Phase 3Taking peopleMetformin versus Tolvaptan in adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD): a phase 3a, independent, multi-centre, 2 parallel arms randomized controlled trial
- Where
- Bari, Bologna, Brescia, cagliari, Catania, Foggia, Messina, Milano, Napoli, Roma, San Giovanni Rotondo, Vicenza, Azienda Ospedaliero-Universitaria di Modena (AOU Modena) - Policlinico di Modena, Azienda Ospedaliera Universitaria Federico II, Complesso Ospedaliero di Belcolle - Ospedale Belcolle
- Age
- 18 years to 64 years
- People
- 150
- Run by
- University Of Bari Aldo Moro
See details and how to joinNCT03764605 · EU 2024-517864-49-01